These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6285182)

  • 1. Iprindole: a cornerstone in the neurobiological investigation of antidepressant treatments.
    de Montigny C
    Mod Probl Pharmacopsychiatry; 1982; 18():102-16. PubMed ID: 6285182
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid response to the addition of lithium in iprindole-resistant unipolar depression: a pilot study.
    de Montigny C; Elie R; Caillé G
    Am J Psychiatry; 1985 Feb; 142(2):220-3. PubMed ID: 3918468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel antidepressants and the biogenic amine hypothesis of depression. The case for iprindole and mianserin.
    Zis AP; Goodwin FK
    Arch Gen Psychiatry; 1979 Sep; 36(10):1097-1107. PubMed ID: 475543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antidepressant and antimanic drugs on amine uptake in man.
    Fann WE; Davis JM; Janowsky DS; Kaufmann JS; Cavanaugh JH; Oates JA
    J Nerv Ment Dis; 1974 May; 158(5):361-8. PubMed ID: 4596092
    [No Abstract]   [Full Text] [Related]  

  • 5. Brain monoamine oxidase activity after in vivo-chronic iprindole treatment.
    Ortega-Corona BG; Carranza J; Sosa A; Guzmán-Amaya P; Esparza-Avalos NS; Castro-Osuna G
    Pharmacol Biochem Behav; 1981 Dec; 15(6):951-4. PubMed ID: 6172802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological treatment of affective disorders (author's transl)].
    Beckmann H
    Nervenarzt; 1981 Mar; 52(3):135-46. PubMed ID: 6111758
    [No Abstract]   [Full Text] [Related]  

  • 7. [Development of biological psychiatric depression research (author's transl)].
    Matussek N
    MMW Munch Med Wochenschr; 1981 May; 123(19):793-4. PubMed ID: 6262640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combined administration of amphetamine and iprindole on brain adrenergic receptors.
    Reisine TD; U'Prichard DC; Wiech NL; Ursillo RC; Yamamura HI
    Brain Res; 1980 Apr; 188(2):587-92. PubMed ID: 6245760
    [No Abstract]   [Full Text] [Related]  

  • 9. A second generation catecholamine hypothesis.
    Bunney WE; Garland BL
    Pharmacopsychiatria; 1982 Jul; 15(4):111-5. PubMed ID: 6292964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen in the treatment of depression: neuropharmacological mechanisms.
    Oppenheim G
    Biol Psychiatry; 1983 Jun; 18(6):721-5. PubMed ID: 6871305
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic applications and mechanisms of action of monoamine oxidase inhibitor and heterocyclic antidepressant drugs.
    Goodman WK; Charney DS
    J Clin Psychiatry; 1985 Oct; 46(10 Pt 2):6-24. PubMed ID: 3900056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New contributions from basic science to understanding the effects of monoamine oxidase inhibiting antidepressants.
    Murphy DL; Garrick NA; Aulakh CS; Cohen RM
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):37-43. PubMed ID: 6735994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of antidepressant agents on beta-adrenergic receptor and neurotransmitter regulatory systems.
    Meyerson LR; Ong HH; Martin LL; Ellis DB
    Pharmacol Biochem Behav; 1980 Jun; 12(6):943-8. PubMed ID: 6105676
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of rabbit mitochondrial monoamine oxidase by iprindole.
    Roth JA; Gillis CN
    Biochem Pharmacol; 1975 Jan; 24(1):151-2. PubMed ID: 1122257
    [No Abstract]   [Full Text] [Related]  

  • 15. Antidepressant mechanisms.
    Goldstein S
    J Am Acad Child Adolesc Psychiatry; 1994 Jan; 33(1):142. PubMed ID: 8138512
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation and adaptation of central norepinephrine receptor systems: modification by antidepressant treatments.
    Sulser F
    Psychiatr J Univ Ott; 1982 Sep; 7(3):196-203. PubMed ID: 6294716
    [No Abstract]   [Full Text] [Related]  

  • 17. The mechanism of action of drugs used to treat attention-deficit hyperactivity disorder: focus on catecholamine receptor pharmacology.
    Shenker A
    Adv Pediatr; 1992; 39():337-82. PubMed ID: 1359740
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased serotonin-2 binding sites in frontal cortex of suicide victims.
    Stanley M; Mann JJ
    Lancet; 1983 Jan; 1(8318):214-6. PubMed ID: 6130248
    [No Abstract]   [Full Text] [Related]  

  • 19. Possible subsensitization of alpha 2-adrenergic receptors by chronic monoamine oxidase inhibitor treatment in psychiatric patients.
    Siever LJ; Uhde TW; Murphy DL
    Psychiatry Res; 1982 Jun; 6(3):293-302. PubMed ID: 6287513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Iprindole: a functional link between serotonin and noradrenaline systems?].
    Ganry H; Bourin M
    Encephale; 1994; 20(1):7-11. PubMed ID: 8174513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.